https://scholars.lib.ntu.edu.tw/handle/123456789/434339
標題: | Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma | 作者: | Chou Y.-Y. YUNG-MING JENG Lee T.-T. Hu F.-C. Kao H.-L. WEI-CHOU LIN Lai P.-L. REY-HENG HU RAY-HWANG YUAN |
公開日期: | 2007 | 卷: | 14 | 期: | 10 | 起(迄)頁: | 2748-2758 | 來源出版物: | Annals of Surgical Oncology | 摘要: | Background: CD24, a mucin like cell surface adhesion molecule and a ligand for P-selectin, has been reported as a prognostic factor in a variety of human cancers. However, the role of CD24 in gastric adenocarcinoma remains largely unknown. Methods: The expression pattern of CD24 in 103 gastric adenocarcinomas (31 diffuse type, 60 intestinal type, and 12 mixed type) was analyzed by immunohistochemistry. Results: Cytoplasmic CD24 expression occurred in 50% of the gastric adenocarcinoma patients and was associated with high-stage tumor (Stage III-IV, P = .023), serosal invasion (SI, P = .010), lymphovascular invasion (LVI, P = .039), and lower 10-year survival (P = .0238). The CD24 staining pattern was different in intestinal and diffuse-type gastric adenocarcinomas. However, the tumor thrombi in lymphovascular spaces exhibited strong cytoplasmic CD24 expression in both types. Further analysis showed that cytoplasmic CD24 expression was, in fact, correlated with high-stage tumor, SI, LVI, and lower 10-year survival significantly (P = .020, P = .007, P = .018, P = .0285, respectively) in diffuse-type gastric adenocarcinoma. Moreover, multivariate analysis showed that cytoplasmic CD24 expression was an independent risk factor of SI and LVI respectively (P = .0083 and P = .0019), and thus it contributed to high-stage tumor and poor patient survival in diffuse- or mixed-type gastric adenocarcinoma. Conclusions: Cytoplasmic expression of CD24 was associated with invasiveness and poorer prognosis and can serve as a novel target for prognostic prediction and adjuvant treatment of patients with diffuse-type gastric adenocarcinoma after tumor resection. ? 2007 The Society of Surgical Oncology, Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-34648820462&doi=10.1245%2fs10434-007-9501-x&partnerID=40&md5=292c389cb29549a68c31fcce4bf015f6 https://scholars.lib.ntu.edu.tw/handle/123456789/434339 |
ISSN: | 1068-9265 | DOI: | 10.1245/s10434-007-9501-x | SDG/關鍵字: | CD24 antigen; adult; aged; article; cancer grading; cancer invasion; cancer patient; cancer risk; cancer survival; cell membrane; female; human; human tissue; immunohistochemistry; lymph node metastasis; major clinical study; male; multivariate analysis; prognosis; protein determination; protein expression; risk factor; stomach adenocarcinoma; survival rate; survival time; tumor thrombus; Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antigens, CD24; Cytoplasm; Female; Humans; Immunoenzyme Techniques; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Serous Membrane; Stomach; Stomach Neoplasms; Survival Analysis; Tumor Markers, Biological |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。